Amphetamine salt, often encountered as a compound in certain pharmaceuticals, presents a fascinating case study in prodrug development. This therapeutic entity isn't the amphetamine molecule itself, but a blend where amphetamine is attached to aspartic acid. Consequently, its absorption profile differs from free amphetamine. The presence of asparta